COPHy Annual Congress
Mar 20 - Mar 21, 2026
Krakow, Poland
Saturday March 21, 8.00 AM CET
Baruch D. Kuppermann, M.D., PhD, and Francesco Bandello, M.D., will be participating in Debate 2 “Novel topical steroids can be an option for the treatment of DME”.
Saturday March 21, 2.20 PM CET
Sharon Klier, M.D., Chief Development Officer of Oculis and Baruch D. Kuppermann, M.D., PhD will be presenting “Visionary Innovation: Visual and Anatomical Improvements Over 12 Weeks with OCS-01 Eye Drops in Patients with Diabetic Macular Edema from the DIAMOND-Stage 1 Trial” as part of the On the Horizon session.